TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Daily Feeding of Food Sources of Cryptoxanthin (CX) and Beta-carotene (BC) on Plasma and Breast Milk Concentrations of CX, BC, and Retinol (VA) in Lactating Women With Marginal Vitamin A Status
Brief Summary: The study will assess the relative bioavailability and bioefficacy of cryptoxanthin (CX) and beta-carotene (BC) from food sources for increasing breast milk carotenoid and retinol concentrations in lactating Bangladeshi women.


Options:
A: Arm Label: 0 mg retinol; Type: PLACEBO_COMPARATOR; Interventions: Other: 0 mg retinol activity equivalents | Arm Label: 12 mg BC; Type: EXPERIMENTAL; Interventions: Other: 12 mg of BC | Arm Label: 6 mg of CX; Type: EXPERIMENTAL; Interventions: Other: 6 mg of CX | Arm Label: 1.0 mg RAE; Type: EXPERIMENTAL; Interventions: Other: 1.0 mg RAE | Intervention Type: OTHER; Name: 0 mg retinol activity equivalents; Assigned to Arm(s): 0 mg retinol | Intervention Type: OTHER; Name: 12 mg of BC; Assigned to Arm(s): 12 mg BC | Intervention Type: OTHER; Name: 6 mg of CX; Assigned to Arm(s): 6 mg of CX | Intervention Type: OTHER; Name: 1.0 mg RAE; Assigned to Arm(s): 1.0 mg RAE
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin A or Beta-Carotene Supplements | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin A or Beta-Carotene Supplements | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Vitamin A or Beta-Carotene Supplements | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin A or Beta-Carotene Supplements; Assigned to Arm(s): 1, 2, 3
C: Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin A; Assigned to Arm(s): N/A
D: Arm Label: Early postpartum vitamin A suppl.; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin A (<3-day postpartum) | Arm Label: Late postpartum vitamin A suppl.; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin A (6 wk postpartum) | Arm Label: Early & late postpartum vitamin A suppl; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin A (<3-day and 6 wk postpartum) | Arm Label: No postpartum vitamin A suppl.; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin A (<3-day postpartum); Assigned to Arm(s): Early postpartum vitamin A suppl. | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin A (6 wk postpartum); Assigned to Arm(s): Late postpartum vitamin A suppl. | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin A (<3-day and 6 wk postpartum); Assigned to Arm(s): Early & late postpartum vitamin A suppl | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): No postpartum vitamin A suppl.

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: RadIal Versus Femoral Randomized InvEstigation in ST Elevation Acute Coronary Syndrome
Brief Summary: Prospective, randomized, multi-center trial comparing the safety and efficacy in the prevention of net adverse clinical outcomes (NACE) of transfemoral vs. transradial approach for the treatment of patients with ST-elevation acute coronary syndrome (STEACS) undergoing primary angioplasty


Options:
A: Arm Label: Eptifibatide; Type: EXPERIMENTAL; Interventions: Drug: Eptifibatide (Integrilin) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Eptifibatide (Integrilin); Assigned to Arm(s): Eptifibatide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: Angiomax (bivalirudin) anticoagulant; Assigned to Arm(s): N/A
C: Arm Label: Radial; Type: EXPERIMENTAL; Interventions: Procedure: Radial approach | Arm Label: Femoral; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Femoral approach | Intervention Type: PROCEDURE; Name: Femoral approach; Assigned to Arm(s): Femoral | Intervention Type: PROCEDURE; Name: Radial approach; Assigned to Arm(s): Radial
D: Arm Label: Early Coronary Intervention; Type: OTHER; Interventions: Procedure: Early Coronary Intervention | Arm Label: Delayed Coronary Intervention; Type: OTHER; Interventions: Procedure: Delayed Coronary Intervention | Intervention Type: PROCEDURE; Name: Early Coronary Intervention; Assigned to Arm(s): Early Coronary Intervention | Intervention Type: PROCEDURE; Name: Delayed Coronary Intervention; Assigned to Arm(s): Delayed Coronary Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tai Chi and Aerobic Exercise for Fibromyalgia
Brief Summary: The investigators will conduct a large randomized controlled trial comparing the effectiveness of Tai Chi mind-body exercise and standard-of-care aerobic exercise for fibromyalgia. In addition, the investigators will determine the optimal frequency and duration of a Tai Chi intervention for short and long-term effectiveness.


Options:
A: Arm Label: Tai Chi Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Tai Chi Intervention | Arm Label: Control Intervention; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control Intervention | Intervention Type: BEHAVIORAL; Name: Tai Chi Intervention; Assigned to Arm(s): Tai Chi Intervention | Intervention Type: BEHAVIORAL; Name: Control Intervention; Assigned to Arm(s): Control Intervention
B: Intervention Type: BEHAVIORAL; Name: self-management program; Assigned to Arm(s): N/A
C: Arm Label: water-based exercise intervention; Type: EXPERIMENTAL; Interventions: Behavioral: water-based exercise | Arm Label: land-based exercise intervention; Type: EXPERIMENTAL; Interventions: Behavioral: land-based exercise intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: water-based exercise; Assigned to Arm(s): water-based exercise intervention | Intervention Type: BEHAVIORAL; Name: land-based exercise intervention; Assigned to Arm(s): land-based exercise intervention
D: Arm Label: Tai Chi; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Lower frequency, shorter period of Tai Chi, Behavioral: Higher frequency, shorter period of Tai Chi, Behavioral: Shorter frequency, longer period of Tai Chi, Behavioral: Higher frequency, longer period of Tai Chi | Arm Label: Aerobic Exercise Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Aerobic Exercise Training | Intervention Type: BEHAVIORAL; Name: Lower frequency, shorter period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Higher frequency, shorter period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Shorter frequency, longer period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Higher frequency, longer period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Aerobic Exercise Training; Assigned to Arm(s): Aerobic Exercise Training

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tai Chi and Aerobic Exercise for Fibromyalgia
Brief Summary: The investigators will conduct a large randomized controlled trial comparing the effectiveness of Tai Chi mind-body exercise and standard-of-care aerobic exercise for fibromyalgia. In addition, the investigators will determine the optimal frequency and duration of a Tai Chi intervention for short and long-term effectiveness.


Options:
A: Arm Label: Tai Chi; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Lower frequency, shorter period of Tai Chi, Behavioral: Higher frequency, shorter period of Tai Chi, Behavioral: Shorter frequency, longer period of Tai Chi, Behavioral: Higher frequency, longer period of Tai Chi | Arm Label: Aerobic Exercise Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Aerobic Exercise Training | Intervention Type: BEHAVIORAL; Name: Lower frequency, shorter period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Higher frequency, shorter period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Shorter frequency, longer period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Higher frequency, longer period of Tai Chi; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: Aerobic Exercise Training; Assigned to Arm(s): Aerobic Exercise Training
B: Intervention Type: BEHAVIORAL; Name: walking program, resistance muscular exercise; Assigned to Arm(s): N/A
C: Arm Label: Interdisciplinary treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Interdisciplinary treatment, Behavioral: Interdisciplinary treatment of fibromyalgia | Arm Label: Usual treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Interdisciplinary treatment; Assigned to Arm(s): Interdisciplinary treatment | Intervention Type: BEHAVIORAL; Name: Interdisciplinary treatment of fibromyalgia; Assigned to Arm(s): Interdisciplinary treatment
D: Arm Label: placebo (P); Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: phototherapy (FT); Type: EXPERIMENTAL; Interventions: Radiation: Group Phototherapy | Arm Label: phototherapy+Physical activity (FT+A); Type: EXPERIMENTAL; Interventions: Radiation: Phototherapy + Physical activity | Arm Label: Physical activity (A); Type: EXPERIMENTAL; Interventions: Other: Physical activity | Intervention Type: RADIATION; Name: Group Phototherapy; Assigned to Arm(s): phototherapy (FT) | Intervention Type: RADIATION; Name: Phototherapy + Physical activity; Assigned to Arm(s): phototherapy+Physical activity (FT+A) | Intervention Type: OTHER; Name: Physical activity; Assigned to Arm(s): Physical activity (A) | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): placebo (P)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Giving BCG Vaccine at Birth to Low Birth-weight Infants on Development of Allergy and Asthma in Childhood - Follow up of a Randomised Trial in Guinea-Bissau
Brief Summary: The prevalence of asthma and allergic diseases is increasing worldwide. Infections and vaccinations in childhood may have an impact on the subsequent development of asthma and allergy. In Guinea-Bissau, the investigators previously found that Bacille Calmette-Guérin (BCG) vaccine was associated with reduction in atopy. Since then the investigators have conducted a randomised trial of BCG vaccine given at birth to low birth-weight infants. The present study aims to follow up children enrolled in the BCG randomised trial to assess for asthma and allergy later in childhood. Based on previous observations, the investigators expect children allocated to receive BCG at birth will have a reduction in allergy profile when compared to children who did not receive BCG at birth.


Options:
A: Arm Label: Low birth-weight cohort; Type: N/A; Interventions: N/A
B: Intervention Type: DRUG; Name: Vitamin A; Assigned to Arm(s): N/A
C: Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin A; Assigned to Arm(s): N/A
D: Arm Label: Vitamin A; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin A (retinyl palmitate). | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Vitamin A (retinyl palmitate). | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin A (retinyl palmitate).; Assigned to Arm(s): Placebo, Vitamin A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Giving BCG Vaccine at Birth to Low Birth-weight Infants on Development of Allergy and Asthma in Childhood - Follow up of a Randomised Trial in Guinea-Bissau
Brief Summary: The prevalence of asthma and allergic diseases is increasing worldwide. Infections and vaccinations in childhood may have an impact on the subsequent development of asthma and allergy. In Guinea-Bissau, the investigators previously found that Bacille Calmette-Guérin (BCG) vaccine was associated with reduction in atopy. Since then the investigators have conducted a randomised trial of BCG vaccine given at birth to low birth-weight infants. The present study aims to follow up children enrolled in the BCG randomised trial to assess for asthma and allergy later in childhood. Based on previous observations, the investigators expect children allocated to receive BCG at birth will have a reduction in allergy profile when compared to children who did not receive BCG at birth.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Peer-support for exclusive breastfeeding | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Peer-support for exclusive breastfeeding; Assigned to Arm(s): Intervention
B: Arm Label: Low birth-weight cohort; Type: N/A; Interventions: N/A
C: Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin A; Assigned to Arm(s): N/A
D: Arm Label: Vitamin A; Type: EXPERIMENTAL; Interventions: Dietary Supplement: retinyl palmitate | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: retinyl palmitate; Assigned to Arm(s): Vitamin A | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Trial: Chinese Auriculotherapy With and Without Protocol on Stress and Quality of Life in Nursing Professionals
Brief Summary: The purpose of this study is to assess stress levels and quality of life in the nursing team of Samaritan Hospital and evaluate the effectiveness of Chinese auriculotherapy used with and without closed protocol on reducing the stress levels and improvement of life quality.


Options:
A: Arm Label: Without Protocol Group; Type: ACTIVE_COMPARATOR; Interventions: Other: without protocol group | Arm Label: Auriculotherapy with protocol; Type: ACTIVE_COMPARATOR; Interventions: Other: Auriculotherapy (protocol group) | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Auriculotherapy (protocol group); Assigned to Arm(s): Auriculotherapy with protocol | Intervention Type: OTHER; Name: without protocol group; Assigned to Arm(s): Without Protocol Group
B: Arm Label: Intervention group 4s (mindfulness); Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness and Mindful Self-Compassion | Arm Label: Intervention group 8s (mindfulness); Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness and Mindful Self-Compassion | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness and Mindful Self-Compassion; Assigned to Arm(s): Intervention group 4s (mindfulness), Intervention group 8s (mindfulness)
C: Arm Label: Within-participant Micro-randomization; Type: EXPERIMENTAL; Interventions: Behavioral: Intern Health Study behavioral change mobile notification, Behavioral: Intern Health Study mobile app | Arm Label: No intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Intern Health Study mobile app | Intervention Type: BEHAVIORAL; Name: Intern Health Study behavioral change mobile notification; Assigned to Arm(s): Within-participant Micro-randomization | Intervention Type: BEHAVIORAL; Name: Intern Health Study mobile app; Assigned to Arm(s): No intervention, Within-participant Micro-randomization
D: Arm Label: Transcendental Meditation Intervention Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Transcendental Meditation | Arm Label: Treatment as usual(TAU) Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Transcendental Meditation; Assigned to Arm(s): Transcendental Meditation Intervention Arm

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effectiveness of Gain- Versus Loss-framed Health Messages to Improve Oral Health Among Iranian Adolescents:A Randomized Controlled Trial
Brief Summary: This study explores the effectiveness of message framing, loss-framed vs. gain-framed messages on oral health in Iran.


Options:
A: Arm Label: Early treatment; Type: EXPERIMENTAL; Interventions: Other: comprehensive dental treatment | Arm Label: Regualr treatment; Type: NO_INTERVENTION; Interventions: Other: Only emergency dental treatment | Intervention Type: OTHER; Name: comprehensive dental treatment; Assigned to Arm(s): Early treatment | Intervention Type: OTHER; Name: Only emergency dental treatment; Assigned to Arm(s): Regualr treatment
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary Advice | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary Advice; Assigned to Arm(s): Intervention
C: Intervention Type: DRUG; Name: Fluoride varnish; Assigned to Arm(s): N/A
D: Arm Label: Loss-framed messages; Type: EXPERIMENTAL; Interventions: Behavioral: Framing (Loss-framed messages) | Arm Label: gain-framed messages; Type: EXPERIMENTAL; Interventions: Behavioral: Framing (Gain-framed messages) | Intervention Type: BEHAVIORAL; Name: Framing (Gain-framed messages); Assigned to Arm(s): gain-framed messages | Intervention Type: BEHAVIORAL; Name: Framing (Loss-framed messages); Assigned to Arm(s): Loss-framed messages

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effectiveness of a Trainings Program on ADL Performance, Physical Fitness, Wellbeing, and Nocturnal Cramp in Elderly People
Brief Summary: Ageing is related to a decrease in physical fitness, disability and age related symptoms like nocturnal leg cramps (NLC). Our research is focused on the enhancement of physical activity and mobility to increase physical fitness and decrease disability and nocturnal cramp in older adults.


Options:
A: Arm Label: Physical training - No encephalopathy; Type: EXPERIMENTAL; Interventions: Other: Physical training, Other: Diet intervention | Arm Label: Control - No encephalopathy; Type: ACTIVE_COMPARATOR; Interventions: Other: Diet intervention | Arm Label: Physical training - Early encephalopathy; Type: EXPERIMENTAL; Interventions: Other: Physical training, Other: Diet intervention | Arm Label: Control - Early encephalopathy; Type: ACTIVE_COMPARATOR; Interventions: Other: Diet intervention | Intervention Type: OTHER; Name: Physical training; Assigned to Arm(s): Physical training - Early encephalopathy, Physical training - No encephalopathy | Intervention Type: OTHER; Name: Diet intervention; Assigned to Arm(s): Control - Early encephalopathy, Control - No encephalopathy, Physical training - Early encephalopathy, Physical training - No encephalopathy
B: Arm Label: exercise; Type: EXPERIMENTAL; Interventions: Other: Fitness exercise program | Intervention Type: OTHER; Name: Fitness exercise program; Assigned to Arm(s): exercise
C: Arm Label: Transdermal Magnesium; Type: EXPERIMENTAL; Interventions: Drug: Transdermal Magnesium | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Transdermal Magnesium; Assigned to Arm(s): Transdermal Magnesium | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: MAGNOX 520®; Type: EXPERIMENTAL; Interventions: Drug: MAGNOX 520® | Arm Label: Similarly looking placebo.; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: MAGNOX 520®; Assigned to Arm(s): MAGNOX 520® | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Similarly looking placebo.

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease
Brief Summary: This is a multi-center trial to further extend the assessment of the safety and efficacy of taliglucerase alfa in adult subjects (≥18 years old) with Gaucher disease who have enrolled in Protocol PB-06-003. Subjects will continue to receive an intravenous (IV) infusion of taliglucerase alfa every two weeks. The duration of treatment will be a maximum of 21 months or until taliglucerase alfa is commercially available to the subject at the discretion of the Sponsor.


Options:
A: Arm Label: Naive 30 Units/kg; Type: EXPERIMENTAL; Interventions: Drug: Taliglucerase alfa | Arm Label: Naive 60 Units/kg; Type: EXPERIMENTAL; Interventions: Drug: Taliglucerase alfa | Arm Label: Switchover; Type: EXPERIMENTAL; Interventions: Drug: Taliglucerase alfa | Intervention Type: DRUG; Name: Taliglucerase alfa; Assigned to Arm(s): Naive 30 Units/kg, Naive 60 Units/kg, Switchover
B: Arm Label: prGCD 30 Units/kg; Type: EXPERIMENTAL; Interventions: Drug: Plant cell expressed recombinant glucocerebrosidase (prGCD) | Arm Label: prGCD 60 Units/kg; Type: EXPERIMENTAL; Interventions: Drug: Plant cell expressed recombinant glucocerebrosidase (prGCD) | Intervention Type: DRUG; Name: Plant cell expressed recombinant glucocerebrosidase (prGCD); Assigned to Arm(s): prGCD 30 Units/kg | Intervention Type: DRUG; Name: Plant cell expressed recombinant glucocerebrosidase (prGCD); Assigned to Arm(s): prGCD 60 Units/kg
C: Arm Label: Taliglucerase alfa 30 units/kg; Type: EXPERIMENTAL; Interventions: Drug: Taliglucerase alfa | Arm Label: Taliglucerase alfa 60 units/kg; Type: EXPERIMENTAL; Interventions: Drug: Taliglucerase alfa | Intervention Type: DRUG; Name: Taliglucerase alfa; Assigned to Arm(s): Taliglucerase alfa 30 units/kg, Taliglucerase alfa 60 units/kg
D: Arm Label: 30 units/kg; Type: EXPERIMENTAL; Interventions: Drug: Taliglucerase alfa | Arm Label: 60 units/kg; Type: EXPERIMENTAL; Interventions: Drug: Taliglucerase alfa | Intervention Type: DRUG; Name: Taliglucerase alfa; Assigned to Arm(s): 30 units/kg, 60 units/kg

Answer: C